|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
27,470,000 |
Market
Cap: |
170.86(M) |
Last
Volume: |
2,592,323 |
Avg
Vol: |
2,568,054 |
52
Week Range: |
$6.22 - $6.22 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Topper James N |
officerTitle |
|
2005-12-14 |
4 |
B |
$0.75 |
$15,000,000 |
I/I |
20,000,000 |
20,000,000 |
2.1 |
- |
|
Wiseman Andrew |
Sen Dir Investor Relations |
|
2005-09-30 |
4 |
A |
$0.61 |
$597 |
D/D |
976 |
20,658 |
|
- |
|
Reilly Teddi |
VP of Human Resources |
|
2005-09-30 |
4 |
A |
$0.61 |
$640 |
D/D |
1,046 |
24,367 |
|
- |
|
Sloan Gail A |
VP of Finance |
|
2005-09-30 |
4 |
A |
$0.61 |
$610 |
D/D |
996 |
16,086 |
|
- |
|
Elchico Josefina T |
Vice President Quality System |
|
2005-09-30 |
4 |
A |
$0.61 |
$3,225 |
D/D |
5,269 |
24,784 |
|
- |
|
Bennett Bruce K Jr |
VP of Manufacturing |
|
2005-09-30 |
4 |
A |
$0.61 |
$5,312 |
D/D |
8,680 |
60,419 |
|
- |
|
Jenn Paul |
VP of Product Development |
|
2005-09-30 |
4 |
A |
$0.61 |
$678 |
D/D |
1,108 |
5,674 |
|
- |
|
Wiseman Andrew |
Sen Dir Investor Relations |
|
2005-06-30 |
4 |
A |
$0.61 |
$667 |
D/D |
1,090 |
19,682 |
|
- |
|
Reilly Teddi |
VP of Human Resources |
|
2005-06-30 |
4 |
A |
$0.61 |
$728 |
D/D |
1,190 |
23,321 |
|
- |
|
Sloan Gail A |
VP of Finance |
|
2005-06-30 |
4 |
A |
$0.61 |
$694 |
D/D |
1,134 |
15,090 |
|
- |
|
Elchico Josefina T |
Vice President Quality System |
|
2005-06-30 |
4 |
A |
$0.61 |
$5,973 |
D/D |
9,759 |
19,515 |
|
- |
|
Bennett Bruce K Jr |
VP of Manufacturing |
|
2005-06-30 |
4 |
A |
$0.61 |
$8,239 |
D/D |
13,463 |
51,739 |
|
- |
|
Jenn Paul |
VP of Product Development |
|
2005-06-30 |
4 |
A |
$0.61 |
$774 |
D/D |
1,264 |
4,566 |
|
- |
|
Elchico Josefina T |
Vice President Quality System |
|
2005-03-31 |
4 |
A |
$0.60 |
$4,615 |
D/D |
7,756 |
9,756 |
|
- |
|
Bennett Bruce K Jr |
VP of Manufacturing |
|
2005-03-31 |
4 |
A |
$0.60 |
$465 |
D/D |
781 |
38,276 |
|
- |
|
Jenn Paul |
VP of Product Development |
|
2005-03-31 |
4 |
A |
$0.60 |
$437 |
D/D |
734 |
3,302 |
|
- |
|
Wiseman Andrew |
Sen Dir Investor Relations |
|
2005-03-31 |
4 |
A |
$0.60 |
$386 |
D/D |
648 |
18,592 |
|
- |
|
Sloan Gail A |
VP of Finance |
|
2005-03-31 |
4 |
A |
$0.60 |
$390 |
D/D |
656 |
13,956 |
|
- |
|
Linnik Matthew D |
CSO & Exec VP of Research |
|
2005-03-31 |
4 |
A |
$0.60 |
$674 |
D/D |
1,133 |
6,497 |
|
- |
|
Heilbrunn Kenneth R |
VP of Clinical Development |
|
2005-03-31 |
4 |
A |
$0.60 |
$671 |
D/D |
1,127 |
12,155 |
|
- |
|
Gonzalez Alejandro |
10% Owner |
|
2005-02-02 |
4 |
B |
$1.50 |
$115,500 |
D/D |
77,000 |
6,864,720 |
2.45 |
- |
|
Gonzalez Alejandro |
10% Owner |
|
2005-01-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,005,000 |
|
- |
|
Gonzalez Alejandro |
10% Owner |
|
2005-01-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,782,720 |
|
- |
|
Wiseman Andrew |
Sen Dir Investor Relations |
|
2004-12-31 |
5 |
A |
$1.42 |
$453 |
D/D |
319 |
17,944 |
|
- |
|
Linnik Matthew D |
CSO & Exec VP of Research |
|
2004-12-31 |
5 |
A |
$1.42 |
$788 |
D/D |
555 |
5,364 |
|
- |
|
567 Records found
|
|
Page 20 of 23 |
|
|